Activus Pharma, Sosei deal

Sosei will acquire drug delivery company Activus. Sosei will gain Activus Pure Nano-particle Technology (APNT), which can yield highly pure 50-300 nm particles for use in injections, ophthalmic solutions and inhalations of poorly soluble compounds. Sosei plans to use the technology to develop its own products and in deals with companies developing branded generics. Sosei said the deal fits its focus on reprofiling drugs for new indications. ...